Chengming Gao, Yahui Wang, Guangming Zhou, Peipei Shi, Ji-Ao Wang, Junjie Wu, Song Liao, Han Yan, Yifei Qiu, Hongbo Yan, Tao Zeng, Ruofan Li, Ying Zhang, Pengbo Cao, Chenning Yang, Jiazhou Ye, Rong Liang, Yuting Wang, Furong Cheng, Kaina Hao, Jinwen Zhang, Xiaoyu Hu, Rui Guo, Qiming Wang, Fuchu He, Yuanfeng Li, Gangqiao Zhou
{"title":"KIF1Bβ通过运输和分泌FBLN5来抑制肝细胞癌,从而减弱整合素通路","authors":"Chengming Gao, Yahui Wang, Guangming Zhou, Peipei Shi, Ji-Ao Wang, Junjie Wu, Song Liao, Han Yan, Yifei Qiu, Hongbo Yan, Tao Zeng, Ruofan Li, Ying Zhang, Pengbo Cao, Chenning Yang, Jiazhou Ye, Rong Liang, Yuting Wang, Furong Cheng, Kaina Hao, Jinwen Zhang, Xiaoyu Hu, Rui Guo, Qiming Wang, Fuchu He, Yuanfeng Li, Gangqiao Zhou","doi":"10.1136/gutjnl-2025-336230","DOIUrl":null,"url":null,"abstract":"Background Our previous genome-wide association study (GWAS) identified that chromosome 1p36.22 locus contributes to the risk of hepatocellular carcinoma (HCC). Objective We aimed to identify the functional causative variant(s) and target gene(s) at this locus. Design Two independent HCC case–control populations, totally consisting of 1934 cases and 1446 controls, were used to validate the association between 1p36.22 locus and HCC risk. The expression quantitative trait locus (eQTL) and eQTL-GWAS co-localisation analyses were used to identify the target gene at 1p36.22. The effects of the target gene on tumourigenesis were assessed in HCC cells, nude mouse models and conditional knockout mouse models. Results We confirmed the association between 1p36.22 locus and HCC risk (p=4.99×10−24), and revealed that this locus is an eQTL of the kinesin family member 1B isoform β ( KIF1Bβ ) gene. Further, we demonstrated that KIF1Bβ plays a tumour suppressive role in HCC in vitro and in vivo. Mechanistically, KIF1Bβ interacts with the cargo Fibulin-5 and mediates its intracellular anterograde transport and extracellular secretion, therefore, reducing the activation of the integrin pathway. We further identified the functional causative variant rs61784580 at 1p36.22, which is located in the promoter of KIF1Bβ and regulates its expression in an allele-specific manner. Finally, we observed that downregulation of KIF1Bβ sensitises HCC cells to integrin αv inhibitor cilengitide. Conclusions Our findings shed light on the genetic and molecular mechanisms of the HCC-associated susceptibility locus at 1p36.22 and provide potential new strategies for the treatment of HCC. Data are available in a public, open access repository. Data are available on reasonable request. Data are available in a public, open access repository. The raw RNA-seq data have been deposited in the Genome Sequence Archive database (GSA-Human: HRA005352). Other data are available on reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information. [dataset] Zhong,[19][1] Johns Hopkins University,[20][2] Schröder et al ,[21][3] Schröder et al ,[22][4] Grinchuk et al ,[23][5] Gao et al .[27][6] [1]: #ref-19 [2]: #ref-20 [3]: #ref-21 [4]: #ref-22 [5]: #ref-23 [6]: #ref-27","PeriodicalId":12825,"journal":{"name":"Gut","volume":"24 1","pages":""},"PeriodicalIF":25.8000,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"KIF1Bβ suppresses hepatocellular carcinoma by transporting and secreting FBLN5 to attenuate the integrin pathway\",\"authors\":\"Chengming Gao, Yahui Wang, Guangming Zhou, Peipei Shi, Ji-Ao Wang, Junjie Wu, Song Liao, Han Yan, Yifei Qiu, Hongbo Yan, Tao Zeng, Ruofan Li, Ying Zhang, Pengbo Cao, Chenning Yang, Jiazhou Ye, Rong Liang, Yuting Wang, Furong Cheng, Kaina Hao, Jinwen Zhang, Xiaoyu Hu, Rui Guo, Qiming Wang, Fuchu He, Yuanfeng Li, Gangqiao Zhou\",\"doi\":\"10.1136/gutjnl-2025-336230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Our previous genome-wide association study (GWAS) identified that chromosome 1p36.22 locus contributes to the risk of hepatocellular carcinoma (HCC). Objective We aimed to identify the functional causative variant(s) and target gene(s) at this locus. Design Two independent HCC case–control populations, totally consisting of 1934 cases and 1446 controls, were used to validate the association between 1p36.22 locus and HCC risk. The expression quantitative trait locus (eQTL) and eQTL-GWAS co-localisation analyses were used to identify the target gene at 1p36.22. The effects of the target gene on tumourigenesis were assessed in HCC cells, nude mouse models and conditional knockout mouse models. Results We confirmed the association between 1p36.22 locus and HCC risk (p=4.99×10−24), and revealed that this locus is an eQTL of the kinesin family member 1B isoform β ( KIF1Bβ ) gene. Further, we demonstrated that KIF1Bβ plays a tumour suppressive role in HCC in vitro and in vivo. Mechanistically, KIF1Bβ interacts with the cargo Fibulin-5 and mediates its intracellular anterograde transport and extracellular secretion, therefore, reducing the activation of the integrin pathway. We further identified the functional causative variant rs61784580 at 1p36.22, which is located in the promoter of KIF1Bβ and regulates its expression in an allele-specific manner. Finally, we observed that downregulation of KIF1Bβ sensitises HCC cells to integrin αv inhibitor cilengitide. Conclusions Our findings shed light on the genetic and molecular mechanisms of the HCC-associated susceptibility locus at 1p36.22 and provide potential new strategies for the treatment of HCC. Data are available in a public, open access repository. Data are available on reasonable request. Data are available in a public, open access repository. The raw RNA-seq data have been deposited in the Genome Sequence Archive database (GSA-Human: HRA005352). Other data are available on reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information. [dataset] Zhong,[19][1] Johns Hopkins University,[20][2] Schröder et al ,[21][3] Schröder et al ,[22][4] Grinchuk et al ,[23][5] Gao et al .[27][6] [1]: #ref-19 [2]: #ref-20 [3]: #ref-21 [4]: #ref-22 [5]: #ref-23 [6]: #ref-27\",\"PeriodicalId\":12825,\"journal\":{\"name\":\"Gut\",\"volume\":\"24 1\",\"pages\":\"\"},\"PeriodicalIF\":25.8000,\"publicationDate\":\"2025-10-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gut\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/gutjnl-2025-336230\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gutjnl-2025-336230","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
KIF1Bβ suppresses hepatocellular carcinoma by transporting and secreting FBLN5 to attenuate the integrin pathway
Background Our previous genome-wide association study (GWAS) identified that chromosome 1p36.22 locus contributes to the risk of hepatocellular carcinoma (HCC). Objective We aimed to identify the functional causative variant(s) and target gene(s) at this locus. Design Two independent HCC case–control populations, totally consisting of 1934 cases and 1446 controls, were used to validate the association between 1p36.22 locus and HCC risk. The expression quantitative trait locus (eQTL) and eQTL-GWAS co-localisation analyses were used to identify the target gene at 1p36.22. The effects of the target gene on tumourigenesis were assessed in HCC cells, nude mouse models and conditional knockout mouse models. Results We confirmed the association between 1p36.22 locus and HCC risk (p=4.99×10−24), and revealed that this locus is an eQTL of the kinesin family member 1B isoform β ( KIF1Bβ ) gene. Further, we demonstrated that KIF1Bβ plays a tumour suppressive role in HCC in vitro and in vivo. Mechanistically, KIF1Bβ interacts with the cargo Fibulin-5 and mediates its intracellular anterograde transport and extracellular secretion, therefore, reducing the activation of the integrin pathway. We further identified the functional causative variant rs61784580 at 1p36.22, which is located in the promoter of KIF1Bβ and regulates its expression in an allele-specific manner. Finally, we observed that downregulation of KIF1Bβ sensitises HCC cells to integrin αv inhibitor cilengitide. Conclusions Our findings shed light on the genetic and molecular mechanisms of the HCC-associated susceptibility locus at 1p36.22 and provide potential new strategies for the treatment of HCC. Data are available in a public, open access repository. Data are available on reasonable request. Data are available in a public, open access repository. The raw RNA-seq data have been deposited in the Genome Sequence Archive database (GSA-Human: HRA005352). Other data are available on reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information. [dataset] Zhong,[19][1] Johns Hopkins University,[20][2] Schröder et al ,[21][3] Schröder et al ,[22][4] Grinchuk et al ,[23][5] Gao et al .[27][6] [1]: #ref-19 [2]: #ref-20 [3]: #ref-21 [4]: #ref-22 [5]: #ref-23 [6]: #ref-27
期刊介绍:
Gut is a renowned international journal specializing in gastroenterology and hepatology, known for its high-quality clinical research covering the alimentary tract, liver, biliary tree, and pancreas. It offers authoritative and current coverage across all aspects of gastroenterology and hepatology, featuring articles on emerging disease mechanisms and innovative diagnostic and therapeutic approaches authored by leading experts.
As the flagship journal of BMJ's gastroenterology portfolio, Gut is accompanied by two companion journals: Frontline Gastroenterology, focusing on education and practice-oriented papers, and BMJ Open Gastroenterology for open access original research.